Monitor stockholder vote on share authorization for the PRSU plan. The aggressive performance targets (e.g., $50M market cap vs current $32M) suggest management confidence in growth, but the dilution is significant if achieved. Watch quarterly filings for progress toward milestones.
Price Chart
Executive Summary
Milestone Scientific implemented a stock option exchange program for its CEO and SVP, repricing underwater options from $0.46-$0.50 to $0.31 per share with accelerated vesting. Additionally, the Compensation Committee approved a new performance-based restricted stock unit (PRSU) sub-plan targeting up to 17.2M shares, subject to stockholder approval, with initial grants of 11.2M PRSUs to three officers tied to aggressive revenue, market cap, and acquisition milestones.
Key Facts
- Option exchange reprices 4 million shares from $0.45-$0.50 to $0.31 per share for CEO Eric Hines and SVP Jason Papes.
- Repriced options vest 25% immediately (500k shares) then 750k shares on each of the next two anniversaries.
- PRSU sub-plan authorizes up to 17,234,635 shares (Aggregate Pool), subject to stockholder approval.
- Initial PRSU grants total 11,202,513 shares: 5,170,391 to CEO Hines, 3,016,061 each to VP Harcum and SVP Papes.
- Performance period is Jan 1, 2026 to Dec 31, 2029; milestones include LTM net sales >$11M, >$13M, >$15M, market cap $50M, and a qualified acquisition >$10M revenue.
Financial Impact
Potential dilution from PRSUs: up to 17.2M new shares (53.8% of current shares if 32M outstanding?), plus 4M repriced options; no immediate cash impact.
Risk Factors
- Massive dilution if all PRSUs vest (up to 17.2M shares); current market cap only $32M.
- PRSU plan requires stockholder approval — failure could void grants.
- Aggressive revenue targets may be unmet, limiting incentive value but avoiding dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-021506 |
| Exhibit: ex10-3.htm | 0001493152-26-021506 |
| Exhibit: ex10-4.htm | 0001493152-26-021506 |
| Exhibit: ex10-1.htm | 0001493152-26-021506 |
| Document: form8-k.htm | 0001493152-26-021506 |
| Document: 0001493152-26-021506-index-headers.html | 0001493152-26-021506 |
| Document: 0001493152-26-021506-index.html | 0001493152-26-021506 |
| Document: 0001493152-26-021506.txt | 0001493152-26-021506 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | EFFECT | $0.4100 $0.3671 | ▲ +10.46% | ▲ +12.41% | $0.3149 (+23.20%) |
Sep 18, 2026 5w ago | S-3/A | $0.3908 $0.4100 | ▲ +4.91% | ▲ +5.93% | $0.3149 (−19.42%) |
Aug 14, 2026 10w ago | Press Release | $0.4951 $0.4808 | ▼ −2.89% | ▼ −1.52% | $0.3149 (−36.40%) |
Jul 31, 2026 12w ago | 8-K | $0.3990 $0.4811 | ▲ +20.58% | ▲ +17.07% | $0.3149 (−21.08%) |
Jul 29, 2026 12w ago | 8-K | $0.3911 $0.4650 | ▲ +18.90% | ▲ +15.27% | $0.3149 (−19.48%) |
Jun 10, 2026 19w ago | EFFECT | $0.3899 $0.3400 | ▲ +12.80% | ▲ +16.23% | $0.3149 (+19.24%) |
Jun 2, 2026 20w ago | S-3 | $0.3900 $0.3900 | · 0.00% | ▼ −3.82% | $0.3149 (+19.26%) |
May 27, 2026 21w ago | Press Release | $0.3900 $0.3900 | · 0.00% | ▼ −1.21% | $0.3149 (−19.26%) |
May 14, 2026 23w ago | Press Release | $0.3400 $0.3900 | ▲ +14.71% | ▲ +15.42% | $0.3149 (−7.38%) |
May 6, 2026 24w ago | 8-K | $0.4700 $0.3500 | ▼ −25.53% | ▼ −27.04% | $0.3149 (−33.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers